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1092Objective: The decision to repair mild-to-moderate functional tricuspid regurgitation (TR) during mitral valve
surgery remains controversial. We evaluated the effects of tricuspid valve (TV) repair for functional mild-to-
moderate TR during mitral valve surgery.
Methods:We enrolled 959 patients with mild-to-moderate functional TR who underwent mitral valve surgery
with (repair group n ¼ 431) or without (control group n ¼ 528) concomitant TV repair from January 1994 to
September 2010.
Results: There were no significant differences in early mortality or major morbidity rates. Median follow-up
was 64.8 months (range, 0.03-203.6 months). After adjustment for baseline characteristics using a propensity
score adjustment model, the repair group had similar risks for TV reoperation (hazard ratio [HR], 0.46; 95%
confidence interval [CI], 0.10-2.07; P ¼ .31); congestive heart failure (HR, 1.12; 95% CI, 0.37-3.36;
P ¼ .84); death (HR, 1.41; 95% CI, 0.82-2.42; P ¼ .22); and the composite of death, TV reoperation, and con-
gestive heart failure (HR, 1.24; 95% CI, 0.76-2.03; P ¼ .39) compared with the control group. On multivariate
Cox-regression analysis, old age, atrial fibrillation without a Maze procedure, diabetes mellitus, chronic renal
failure, poor left ventricular ejection fraction, and redo surgery emerged as significant independent risk factors
for the composite outcome of death, TV reoperation, and congestive heart failure.
Conclusions: Early or late clinical benefits of concomitant TV repair for mild-to-moderate TR during mitral
valve surgery were uncertain through a long-term follow-up of 959 patients. Several preoperative factors and
the performance of Maze procedure for AF seem to be more important than TV repair in overall clinical
outcomes. (J Thorac Cardiovasc Surg 2013;146:1092-7)Functional tricuspid regurgitation (TR) is common in pa-
tients with longstanding left heart valve disease.1 Although
functional TR might improve after correction of left heart
lesions,2 uncorrected significant TR is reported to progress
in almost half of patients,3 and increase postoperative
mortality and morbidity.4 The significance of overlooked
functional TR was recently affirmed and several studies
reported on concomitant repair of functional TR. Severe
TR in patients with mitral valve (MV) disease requiring
MV surgery is a definite indication (Class I) for concurrent
tricuspid valve (TV) repair.5,6 However, the decision to
repair lesser degree of functional TR during MV surgery
is not well defined, and the optimal strategy for treatment
of functional TR remains controversial.e Department of Thoracic and Cardiovascular Surgery, Asan Medical Center,
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The Journal of Thoracic and Cardiovascular SurTherefore, we reviewed patients with mild-to-moderate
TR who underwent left heart valve surgery to determine
how TV repair affects the clinical and echocardiographic
outcomes and to identify factors associated with mortality,
TV reoperation, or congestive heart failure (CHF) after MV
surgery.
PATIENTS AND METHODS
Study Population
From January 1994 to September 2010, 5,634 patients aged 18 years
underwent surgery for left heart valve disease at Asan Medical Center,
Seoul, South Korea. Among these, patients with coronary disease requiring
intervention (n ¼ 612) were excluded. Of the remaining 5022 patients,
1116 patients had mild-to-moderate functional TR on preoperative echo-
cardiogram and 959 patients were finally enrolled after excluding patients
with nonmitral pathology (n ¼ 157). Functional TR was defined as TR
without definite organic leaflet or subvalvular deformities, such as TV pro-
lapse, rheumatic involvement, infective endocarditis, or Ebstein anomaly.
Of the 959 with mild-to-moderate functional TR, 431 patients underwent
concomitant TV repair (repair group) and 528 patients did not (control
group).
This study was approved by our institutional Ethics Committee/Review
Board, which waived the requirement for informed patient consent because
of the retrospective nature of this study.
Echocardiographic Evaluation
Two-dimensional echocardiography and Doppler color-flow imaging
were performed on all patients using a Hewlett-Packard Sonos 2500 orgery c November 2013
TABLE 1. Baseline and operative characteristics
Repair
group
Nonrepair
group P
No. of patients 431 528
Age (y) 53.3  13.2 49.1  12.3 <.001
Man 152 (35.3) 228 (43.2) .013
Diabetes mellitus 30 (7.0) 29 (5.5) .35
Hypertension 59 (13.7) 77 (14.6) .69
Chronic renal failure 3 (0.7) 2 (0.4) .66
Redo open heart surgery 26 (6.0) 7 (1.3) <.001
Atrial fibrillation 303 (70.3) 288 (54.5) <.001
Maze procedure 194 (45.0) 185 (35.0) <.001
History of thromboembolic events 32 (7.4) 46 (8.7) .47
Stroke 29 (6.7) 38 (7.2) .78
Other thromboembolic events 3 (0.7) 9 (1.7) .24
Mitral valve pathology
Mitral regurgitation 244 (56.6) 260 (49.2) .073
Mitral stenosis 129 (29.9) 182 (34.5) .073
Mixed lesion 58 (13.5) 86 (16.3) .073
Tricuspid regurgitation
Mild 150 (34.8) 495 (93.8) <.001
Moderate 281 (65.2) 33 (6.3) <.001
LV ejection fraction (%) 55.9  9.7 58.3  9.0 <.001
LV end-systolic dimension (mm) 39.0  8.1 38.0  6.8 .044
LV end-diastolic dimension (mm) 56.6  9.7 56.8  8.6 .81
Left atrial dimension (mm) 60.2  11.9 56.7  10.1 <.001
Trans TV pressure gradient
(mm Hg)
45.0  17.3 35.5  14.7 <.001
Surgery type
MVP 184 (42.7) 222 (42.0) .84
MVR 247 (57.3) 306 (58.0) .84
MICS 87 (20.2) 128 (24.2) .13
Data are presented as mean standard deviation or number (%). LV, Left ventricular;
TV, tricuspid valve;MVP, mitral valve repair;MVR, mitral valve replacement;MICS,
minimally invasive cardiac surgery.
Abbreviations and Acronyms
AF ¼ atrial fibrillation
CHF ¼ congestive heart failure
LVEF ¼ left ventricular ejection fraction
MV ¼ mitral valve
TR ¼ tricuspid regurgitation
TV ¼ tricuspid valve
Ro et al Acquired Cardiovascular Disease
A
C
D5500 imaging system equipped with a 2.5-MHz transducer (Hewlett-Pack-
ard, Andover, Mass). All patients underwent transthoracic echocardio-
graphic evaluation before operation.
The degree of TR was evaluated using the apical 4-chamber view, and
graded as mild, moderate, or severe when the distal jet area was<5 cm2,
5 to 10 cm2, or>10 cm2, respectively.7 The peak systolic TR jet velocity
measured by continuous-wave Doppler was used to calculate the TR
peak pressure gradient using the simplified Bernoulli equation (pressure
gradient ¼ 4 3 velocity2) to estimate the peak systolic pulmonary artery
pressure.
Surgical Procedures
The decision to perform TV repair was affected by the degree of TR,
tricuspid annular dimension, left ventricular function, combined proce-
dures, and the presence of atrial fibrillation; but was ultimately at the
discretion of the attending surgeon. Because TV annular dimension was
not routinely measured pre- or intraoperatively, annular size was not an
indispensable indicator for combination of TV repair. In cases of TV repair,
TR was repaired by suture annuloplasty, ring annuloplasty, or both, and
surgical techniques were determined based on each surgeon’s preference.
Minimally invasive cardiac surgeries included right minithoracotomy,
upper sternotomy, and lower sternotomy, and Maze procedures were
performed by a modified Cox-Maze III technique using cryoablation or
a microwave source.
Follow-up
Data were obtained from medical charts during regular visits to the out-
patient clinic or by telephone contact. Vital status data were acquired from
the Korean National Registry of vital statistics. Operative mortality was
defined as death within 30 days after surgery.
The primary end points of this study included all-cause mortality, TV
reoperation, and re-admission for CHF. The secondary end points were
the composite of valve-related complications, which included thromboem-
bolic events, anticoagulation-related hemorrhage, reoperation for left-
sided valves, and infective endocarditis. Readmission for CHF was defined
as an unplanned and urgent admission for management of CHF.
Anticoagulation-related hemorrhage was defined as any requirement for
transfusion, unplanned admission, or a hemostatic intervention associated
with prolonged prothrombin time.
Postoperative TR grade and left ventricular ejection fraction (LVEF)
were obtained from the final postoperative echocardiogram obtained after
6 months in patients who survived>6 months.
Statistical Analysis
Categorical variables are presented as numbers and percentages and
were compared using the c2 and Fisher exact tests. Continuous variables
are expressed as mean  standard deviation and were compared using
the t test or the Mann-Whitney U test, as appropriate. To adjust for differ-
ences in the baseline patient characteristics between groups, propensity
score analysis was performed. The propensity scores were estimated
without regard to outcome variables through binary logistic regression
analysis incorporating 17 prespecified covariates listed in Table 1. TheThe Journal of Thoracic and Cardiscrimination and calibration ability of the propensity score model was as-
sessed using the C statistic and the Hosmer-Lemeshow statistic. The model
was well calibrated (Hosmer-Lemeshow test P¼ .707) with reasonable dis-
crimination (C statistic, 0.880). The hazard of concomitant TV repair af-
fecting the clinical outcomes compared with nonrepair was analyzed
using the Cox regression model without and with adjustment by propensity
scores. Cumulative incidence rates of individual and composite outcomes
were also estimated using Cox regression model. Multivariable risk factors
for the composite of death, TV reoperation, and CHF requiring readmission
were obtained using the Cox proportional hazards model. Variables with
a P value.20 on univariate analyses were candidates for the multivariable
models. Multivariable analyses involved a backward elimination tech-
nique, and only variables with a P value<.10 were used in the final model.
To compare postoperative echocardiographic outcomes between the
groups, propensity score matching was performed. In patients who
had follow-up echocardiogram, propensity scores were re-estimated
(Hosmer-Lemeshow test P ¼ .350; C statistic, 0.877). To develop the pro-
pensity score-matched pairs without replacement (a 1:1 match), the Greedy
5 to 1 digit match algorithm was used.8,9 After propensity score matching,
the baseline covariates were compared between the groups using the paired
t test or the Wilcoxon signed-rank test for continuous variables and the
McNemar test or marginal homogeneity test for categorical variables.
SPSS software version 18.0 (IBM, Armonk, NY) was used for statistical
analyses.diovascular Surgery c Volume 146, Number 5 1093
TABLE 2. Operative outcomes
Repair
group
Nonrepair
group P
Early outcomes
Operative mortality 7 (1.6) 3 (0.6) .12
Early complications 67 (15.5) 71 (13.4) .36
Sternal bleeding 30 (7.0) 23 (4.4) .079
Pericardial effusion 10 (2.3) 19 (3.6) .25
Wound problem 6 (1.4) 11 (2.1) .47
Permanent pacemaker insertion 7 (1.6) 2 (0.4) .087
Low cardiac output syndrome 6 (1.4) 3 (0.6) .31
Requirement for dialysis 13 (3.0) 0 (0) <.001
Mediastinitis 0 (0) 1 (0.2) >.99
Neurologic complication 6 (1.4) 3 (0.6) .31
Primary end point 77 (17.9) 53 (10.0) <.001
Death 64 (14.8) 38 (7.2) <.001
Tricuspid valve reoperation 6 (1.4) 8 (1.5) >.99
Admission due to heart failure 16 (3.7) 10 (1.9) .11
Other late complications 37 (8.6) 48 (9.1) .78
Stroke 13 (3.0) 17 (3.2) .86
Anticoagulation-related hemorrhages* 18 (4.2) 24 (4.5) .78
Reoperation, other causesy 7 (1.6) 12 (2.3) .64
Infective endocarditis 0 (0.0) 2 (0.4) .51
Data are presented as number (%). *Hemorrhage related to prolonged prothrombin
time requiring transfusion. yReoperation due to valvular heart lesions other than
tricuspid valve.
TABLE 3. Unadjusted and adjusted hazard ratio (HR) and 95%
confidence interval (CI) of clinical outcomes for tricuspid valve
repair compared with nonrepair
Crude Adjusted
HR 95% CI P HR 95% CI P
Death 1.76 1.17-2.65 .007 1.41 0.82-2.42 .22
TV reoperation 0.74 0.24-2.24 .59 0.46 0.10-2.07 .31
CHF admission 1.84 0.83-4.12 .14 1.12 0.37-3.36 .84
Primary outcome* 1.66 1.16-2.38 .006 1.24 0.76-2.03 .39
Composite outcome
(primaryþsecondary
outcomesy)
1.49 1.10-2.00 .01 1.19 0.79-1.80 .40
TV, Tricuspid valve; CHF, congestive heart failure; HR, hazard ratio; CI, clinical out-
comes. *Composite of death, tricuspid reoperation, and readmission due to heart fail-
ure. yComposite of valve-related complications, including thromboembolic events,
anticoagulation-related hemorrhage, and reoperation for valvular lesions other than
tricuspid valve or infective endocarditis.
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DRESULTS
Baseline Characteristics
Preoperative baseline patient characteristics are summa-
rized in Table 1. Patients in the repair group had higher clin-
ical and echocardiographic risk factors than those in the
control group as evidenced by older age (P<.001), more
history of previous cardiac surgery (P<.001), higher prev-
alence of atrial fibrillation (AF) (P<.001), more severe TR
(P<.001), and poorer LVEF (P<0.001).
Five hundred four patients (52.6%) underwent MV sur-
gery for mitral regurgitation, 311 patients (32.4%) for mi-
tral stenosis, and 144 patients (15.0%) for mixed lesion in
total cohort. There were no significant between-group dif-
ferences according to the etiology of the MV disease
(P ¼ .073) (Table 1). The Maze procedure was concomi-
tantly performed in 194 patients (45.0%) in the repair group
and 185 patients (35.0%) in the control group (Table 1).
MV repair was performed in 406 patients (42.3%) in total
cohort.Clinical Outcomes
Perioperative results. Cardiopulmonary bypass (146.3 
55.9 minutes vs 115.0  45.8 minutes; P<.001) and aortic
cross-clamp (95.9  35.9 minutes vs 73.9  33.6 minutes;
P<.001) times were significantly longer in the repair group
than in the control group. The operative mortality rate was
1.0% (n ¼ 10). There were no significant differences in
early mortality (1.6% vs 0.6%; P¼ .12) or major morbidity
rates (15.5% vs 13.4%; P ¼ .36) (Table 2).1094 The Journal of Thoracic and Cardiovascular SurPrimary and secondary end points. During a median
clinical follow-up period of 64.8 months (range, 0.03-
203.6 months), there were 102 late deaths, 14 cases of TV
reoperation, and 26 readmissions for CHF. There were no
significant differences in the frequency of TV reoperation
and re-admission for CHF between the groups; however,
late deaths were more frequent in the repair group than in
the control group (14.8% vs 7.2%; P< .001) (Table 2).
Both groups had similar risk for other late complications
affected by valve surgery, such as stroke, significant hemor-
rhage related to anticoagulation, reoperation due to valvular
heart lesions other than TV, or infective endocarditis.
The hazard of concomitant TV repair compared with
nonrepair was estimated without adjustment and with ad-
justment (Table 3). After adjustment for baseline character-
istics using a propensity score model, patients in the repair
group had similar risk of death (hazard ratio [HR], 1.41;
95% confidence interval [CI], 0.82-2.42; P¼ .22), readmis-
sion for CHF (HR, 1.12; 95% CI, 0.37-3.36; P ¼ .84), pri-
mary outcomes (HR, 1.24; 95% CI, 0.76-2.03; P ¼ .39),
and the composite of all adverse events (HR, 1.19; 95%
CI, 0.79-1.80; P ¼ .40) as those in the control group. Al-
though there was a trend for lower risk of TV reoperation
in the repair group, it was not statistically significant (HR,
0.46; 95% CI, 0.10-2.07; P ¼ .31) (Table 3 and Figure 1).
Independent risk factors for the primary end point.
Multivariate Cox regression analysis was performed to
determine the independent risk factors for the primary out-
comes (Table 4). Age (HR, 1.04; 95% CI, 1.03-1.06;
P<.001), AF without a Maze procedure (HR, 1.66; 95%
CI, 1.05-2.63; P ¼ .030), diabetes mellitus (HR, 2.08;
95% CI, 1.21-3.57; P ¼ .008), chronic renal failure (HR,
4.28; 95% CI, 1.04-17.66; P ¼ .044), poor LVEF (HR,
1.32; 95% CI, 1.10-1.56; P¼ .003), and history of previous
open heart surgery (HR, 2.52; 95%CI, 1.26-5.05; P¼ .009)
emerged as significant independent risk factors for the
primary outcomes.gery c November 2013
FIGURE 1. The cumulative incidence rates of clinical end points in the repair and control groups after adjustment. A, Overall survival. B, Freedom from
tricuspid valve (TV) reoperation. C, Freedom from congestive heart failure (CHF) requiring readmission. D, Freedom from the composite of death,
TV reoperation, and CHF requiring readmission. HR, Hazard ratio; CI, confidence interval.
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Between the 2 Groups: Propensity Score Matching
Of 939 survivors>6 months after surgery, 844 patients
(89.9%) had follow-up echocardiogram for >6 months.
Median follow-up duration was 69.2  44.2 months, with
a range of 6.0 to 203.6 months. Propensity score matching
for the 844 patients yielded 144 matched pairs of patients.
In the matched cohort, there were no significant between-
group differences for any baseline covariates (Table 5).
Median follow-up durations were 68.1 months (range,
7.3-199.3 months) in the repair group and 64.6 months
(range, 7.2-196.5 months) in the control group (P ¼ .16).
Preoperative and postoperative TR grades were com-
pared between the 2 groups in the matched cohortTABLE 4. Multivariate Cox regression analysis to identify
independent risk factors for the composite of death, tricuspid valve
reoperation, and congestive heart failure
Hazard
ratio
95% confidence
interval P
Age (y) 1.04 1.03-1.06 <.001
AF without Maze 1.66 1.05-2.63 .030
Diabetes mellitus 2.08 1.21-3.57 .008
Chronic renal failure 4.28 1.04-17.66 .044
LV ejection fraction (by 10%) 0.76 0.64-0.91 .003
Redo surgery 2.52 1.26-5.05 .009
MICS 0.57 0.29-1.10 .095
AF, Atrial fibrillation; LV, left ventricular;MICS, minimally invasive cardiac surgery.
The Journal of Thoracic and Car(n ¼ 288) (Figure 2). There were no between-group differ-
ences in preoperative TR grades (P> .99) (Figure 2, A);
however, comparing the severity of TR at the last follow-
up, patients with greater than moderate TR were signifi-
cantly less common in the repair group compared with
those in the control group (10.4% vs 13.9%; P ¼ .023)
(Figure 2, B).
DISCUSSION
Several studies have shown that uncorrected significant
functional TR after left heart valve surgery is associated
with increased mortality and morbidity4,10-12 and decreased
functional outcome.10,13-15 However, data are limited with
regard to whether uncorrected functional TR will progress
despite resolution of the left heart lesion responsible for
overloading the right ventricle. Updated guidelines of
the American College of Cardiology/American Heart
Association regarding valve disease suggest that TV repair
is beneficial for severe TR in patients with MV disease
requiring MV surgery (Class I, level of evidence: B).5 Ac-
cording to these guidelines, however, less than severe TR in
patients undergoing MV surgery is not a definite indication
for tricuspid annuloplasty (Class IIb, level of evidence: C).
The European Society of Cardiology guidelines on the
management of valvular heart disease also state that severe
TR in a patient undergoing left-sided valve surgery is the
only definite indication for TV repair (Class I, level of
evidence: C).6diovascular Surgery c Volume 146, Number 5 1095
TABLE 5. Baseline characteristics of propensity score matched
groups
Repair
group
Nonrepair
group P
No. of patients 144 144
Age (y) 50.5  13.6 50.2  11.8 .79
Man 54 (37.5) 64 (44.4) .27
Diabetes mellitus 9 (6.3) 6 (4.2) .61
Hypertension 18 (12.5) 19 (13.2) >.99
Chronic renal failure 0 (0.0) 0 (0.0) NC
Redo open heart surgery 6 (4.2) 6 (4.2) >.99
Atrial fibrillation 95 (66.0) 98 (68.1) .065
Maze procedure 72 (50.0) 77 (53.5) .065
History of thromboembolic events 9 (6.3) 5 (3.5) .42
Stroke 8 (5.6) 4 (2.8) .39
Other thromboembolic events 1 (0.7) 1 (0.7) >.99
Tricuspid regurgitation
Mild 117 (81.3) 117 (81.3) >.99
Moderate 27 (18.8) 27 (18.8) >.99
LV ejection fraction (%) 56.5  9.2 56.4  9.9 .93
LV end-systolic dimension (mm) 39.1  7.4 39.9  7.4 .33
LV end-diastolic dimension (mm) 57.2  9.7 58.0  9.7 .50
Left atrial dimension (mm) 59.1  12.3 59.5  11.2 .81
Trans TV pressure
gradient (mm Hg)
40.2  14.6 39.5  17.4 .68
Surgery type
MVP 67 (46.5) 66 (45.8) >.99
MVR 77 (53.5) 78 (54.2) >.99
MICS 40 (27.8) 34 (23.6) .47
Data are presented as mean standard deviation or number (%). LV, Left ventricular;
TV, tricuspid valve;MVP, mitral valve repair;MVR, mitral valve replacement;MICS,
minimally invasive cardiac surgery.
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DRecently, as the significance of TR has been addressed,
a few studies have reported on mild-to-moderate TR.
Song and colleagues15 reported that 7.7% of untreated
mild TR progressed to late significant TR despite successful
left-sided valve surgery through a retrospective study in-
volving 638 patients during a mean follow-up period of
64 months. Because late significant TR was associated
with worse clinical outcomes, they suggested that aggres-
sive surgical intervention may be considered in patients
with risk factors for developing late significant TR. Another
retrospective comparison of surgical and conservative
treatment for mild-to-moderate functional TR showed that
concomitant TV repair with MV repair or replacement de-
creased right ventricular diameter and the average grade
of TR.16 Kim and colleagues17 reported a retrospective
study of 236 patients with mild-to-moderate functional
TR who underwent MV replacement for rheumatic MV
disease. In their study, concomitant TV repair for mild-to-
moderate functional TR was associated with better postop-
erative TV function.
Dreyfus and colleagues3 recommended that the TV
annulus should be measured at the time of left heart valve
surgery and tricuspid dilatation should be corrected1096 The Journal of Thoracic and Cardiovascular Surregardless of the severity of TR because TV disease is cor-
related with tricuspid dilatation rather than the degree of
TR. They measured the tricuspid annular diameter intrao-
peratively from the anteroseptal commissure to the antero-
posterior commissure. Patients with a tricuspid annular
dimension 70 mm underwent tricuspid annuloplasty,
which improved functional status.
Yilmaz and colleagues18 analyzed changes in the degree
of functional TR in 699 patients who underwent MV repair
for degenerative MV disease. Their data demonstrated that
the progression of TR in patients undergoing MV repair is
unusual, and that coexistent TR did not affect late mortality.
The authors emphasized the significance of preoperative co-
morbidities in the determination of clinical outcomes rather
than the presence of functional TR. In agreement with their
report, our study also showed that several preoperative fac-
tors and the performance of Maze procedure for AF had
more clinical significance in the determination of overall
outcomes than the concomitant TV repair.
In our study, concomitant TV repair was not associated
with better clinical outcomes, but did result in better TR
grades. These results are not much different from other ret-
rospective studies, although the size of our study was larger
and the disease entity was extended to entire MV disease. In
other words, better TV function did not seem to affect long-
term clinical outcomes in this study. Rather, several preop-
erative factors such as age, diabetes mellitus, chronic renal
failure, LVEF, history of cardiac surgery, and the perfor-
mance of Maze procedure for patients with AF seem to be
more important in overall clinical outcomes. However, con-
sidering that it takes longer time for significant TR to affect
heart function, compared with the clinical course of left
sided valve disease; the clinical follow-up period of this
study may not be long enough to verify the efficacy of con-
comitant TV repair.
Limitations
Our study was retrospective in nature and nonrandom-
ized.Moreover, surgical indications and surgical techniques
were not uniform among surgeons who did or did not per-
form concomitant TV repair. In the matched cohort,
81.3% of patients had mild TR and only 18.8% had moder-
ate TR. Therefore, the study results may mainly represent
those of patients with mild TR, and the conclusions on pa-
tients with moderate TR may not be as robust as for patients
with mild TR. These limitations might have affected our re-
sults, although rigorous statistical adjustment was used for
analysis. Echocardiographic values that are associated
with the right heart, such as tricuspid annular dimension,
TV tethering distance, and TV tethering area could not be
routinely estimated, and right ventricular function was not
quantified. The median follow-up period of this study was
64.8 months (ie, 5 years), which may not be long enough
to interpret the effect of significant TR on clinical outcomes.gery c November 2013
FIGURE 2. Comparison of the severity of tricuspid regurgitation between the groups using propensity score matching. A, Preoperative severity of tricuspid
regurgitation. B, Postoperative severity of tricuspid regurgitation at the final follow-up.
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DCONCLUSIONS
The clinical benefit of concomitant TV repair for mild-to-
moderate concomitant functional TR duringMV surgery re-
mains uncertain. Risk factors such as age, diabetes mellitus,
chronic renal failure, poor LVEF, history of prior cardiac
surgery, and concomitant Maze procedure for AF seem to
be more important than TV repair on late clinical outcome.
Concomitant TV repair cannot therefore be routinely
recommended in this patient population at the time of MV
repair or replacement.
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